{
      "StudyFieldsResponse": {
            "APIVrs": "1.01.05",
            "DataVrs": "2022:10:06 23:25:58.836",
            "Expression": "mesenchymal COVI-MSC",
            "NStudiesAvail": 430108,
            "NStudiesFound": 6,
            "MinRank": 1,
            "MaxRank": 1000,
            "NStudiesReturned": 6,
            "FieldList": [
                  "BriefSummary",
                  "BriefTitle",
                  "CentralContactEMail",
                  "CentralContactName",
                  "CentralContactPhone",
                  "CentralContactPhoneExt",
                  "CentralContactRole",
                  "CollaboratorClass",
                  "CollaboratorName",
                  "CompletionDate",
                  "CompletionDateType",
                  "Condition",
                  "ConditionAncestorId",
                  "ConditionAncestorTerm",
                  "ConditionBrowseBranchAbbrev",
                  "NCTId"
            ],
            "StudyFields": [
                  {
                        "Rank": 1,
                        "BriefSummary": [
                              "This is a Phase 1b study to assess the safety and efficacy of COVI-MSC in treating post COVID-19 \"long haulers\" with pulmonary compromise."
                        ],
                        "BriefTitle": [
                              "Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells to Treat Post COVID-19 \"Long Haul\" Pulmonary Compromise"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "January 2022"
                        ],
                        "CompletionDateType": [
                              "Anticipated"
                        ],
                        "Condition": [
                              "Covid19"
                        ],
                        "ConditionAncestorId": [
                              "D000012141",
                              "D000007239",
                              "D000011024",
                              "D000011014",
                              "D000014777",
                              "D000018352",
                              "D000003333",
                              "D000030341",
                              "D000012327",
                              "D000008171",
                              "D000012140"
                        ],
                        "ConditionAncestorTerm": [
                              "Respiratory Tract Infections",
                              "Infections",
                              "Pneumonia, Viral",
                              "Pneumonia",
                              "Virus Diseases",
                              "Coronavirus Infections",
                              "Coronaviridae Infections",
                              "Nidovirales Infections",
                              "RNA Virus Infections",
                              "Lung Diseases",
                              "Respiratory Tract Diseases"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC01",
                              "BC08",
                              "All",
                              "BC23",
                              "Rare"
                        ],
                        "NCTId": [
                              "NCT04909892"
                        ]
                  },
                  {
                        "Rank": 2,
                        "BriefSummary": [
                              "This is a Phase 2 study to assess COVI-MSC in the setting of current standard of care in hospitalized subjects with RT-PCR confirmed SARS-CoV-2 (COVID-19) infection and acute respiratory distress / acute respiratory distress syndrome."
                        ],
                        "BriefTitle": [
                              "Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treatment of COVID-19 Acute Respiratory Distress"
                        ],
                        "CentralContactEMail": [
                              "mroyal@sorrentotherapeutics.com"
                        ],
                        "CentralContactName": [
                              "Mike Royal, MD"
                        ],
                        "CentralContactPhone": [
                              "(858) 203-4100"
                        ],
                        "CentralContactPhoneExt": [
                              "4146"
                        ],
                        "CentralContactRole": [
                              "Contact"
                        ],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "March 2023"
                        ],
                        "CompletionDateType": [
                              "Anticipated"
                        ],
                        "Condition": [
                              "Covid19"
                        ],
                        "ConditionAncestorId": [
                              "D000012141",
                              "D000007239",
                              "D000011024",
                              "D000011014",
                              "D000014777",
                              "D000018352",
                              "D000003333",
                              "D000030341",
                              "D000012327",
                              "D000008171",
                              "D000012140"
                        ],
                        "ConditionAncestorTerm": [
                              "Respiratory Tract Infections",
                              "Infections",
                              "Pneumonia, Viral",
                              "Pneumonia",
                              "Virus Diseases",
                              "Coronavirus Infections",
                              "Coronaviridae Infections",
                              "Nidovirales Infections",
                              "RNA Virus Infections",
                              "Lung Diseases",
                              "Respiratory Tract Diseases"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC01",
                              "BC08",
                              "All",
                              "BC23",
                              "Rare"
                        ],
                        "NCTId": [
                              "NCT04905836"
                        ]
                  },
                  {
                        "Rank": 3,
                        "BriefSummary": [
                              "This is a Phase 2 randomized study to assess the safety and efficacy of COVI-MSC in the setting of current standard of care treatments for subjects hospitalized subjects with acute respiratory distress syndrome not related to COVID-19 infection."
                        ],
                        "BriefTitle": [
                              "Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Non-COVID-19 Acute Respiratory Distress Syndrome"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "April 2022"
                        ],
                        "CompletionDateType": [
                              "Anticipated"
                        ],
                        "Condition": [
                              "Acute Respiratory Distress Syndrome",
                              "Ards"
                        ],
                        "ConditionAncestorId": [
                              "D000004194",
                              "D000010335",
                              "D000008171",
                              "D000012140",
                              "D000012120",
                              "D000007235",
                              "D000007232",
                              "D000055370"
                        ],
                        "ConditionAncestorTerm": [
                              "Disease",
                              "Pathologic Processes",
                              "Lung Diseases",
                              "Respiratory Tract Diseases",
                              "Respiration Disorders",
                              "Infant, Premature, Diseases",
                              "Infant, Newborn, Diseases",
                              "Lung Injury"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC01",
                              "BC08",
                              "All",
                              "BC23",
                              "BC16",
                              "BC26",
                              "BXS",
                              "Rare"
                        ],
                        "NCTId": [
                              "NCT04909879"
                        ]
                  },
                  {
                        "Rank": 4,
                        "BriefSummary": [
                              "This is a Phase 2a randomized, placebo-controlled study designed to investigate the efficacy, safety and tolerability of COVI-MSC in treating post COVID-19 \"long haul\" pulmonary compromise."
                        ],
                        "BriefTitle": [
                              "Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells to Treat Post COVID-19 \"Long Haul\" Pulmonary Compromise"
                        ],
                        "CentralContactEMail": [
                              "mroyal@sorrentotherapeutics.com"
                        ],
                        "CentralContactName": [
                              "Mike Royal, MD"
                        ],
                        "CentralContactPhone": [
                              "(858)203-4100"
                        ],
                        "CentralContactPhoneExt": [
                              "4146"
                        ],
                        "CentralContactRole": [
                              "Contact"
                        ],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "September 2023"
                        ],
                        "CompletionDateType": [
                              "Anticipated"
                        ],
                        "Condition": [
                              "Covid19"
                        ],
                        "ConditionAncestorId": [
                              "D000012141",
                              "D000007239",
                              "D000011024",
                              "D000011014",
                              "D000014777",
                              "D000018352",
                              "D000003333",
                              "D000030341",
                              "D000012327",
                              "D000008171",
                              "D000012140"
                        ],
                        "ConditionAncestorTerm": [
                              "Respiratory Tract Infections",
                              "Infections",
                              "Pneumonia, Viral",
                              "Pneumonia",
                              "Virus Diseases",
                              "Coronavirus Infections",
                              "Coronaviridae Infections",
                              "Nidovirales Infections",
                              "RNA Virus Infections",
                              "Lung Diseases",
                              "Respiratory Tract Diseases"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC01",
                              "BC08",
                              "All",
                              "BC23",
                              "Rare"
                        ],
                        "NCTId": [
                              "NCT04992247"
                        ]
                  },
                  {
                        "Rank": 5,
                        "BriefSummary": [
                              "This is a Phase 2, randomized controlled, multicenter study to assess the safety and efficacy of COVI-MSC in the setting of current standard of care (SOC) treatments for COVID-19 infection in hospitalized subjects with ARD/ARDS."
                        ],
                        "BriefTitle": [
                              "Study of Intravenous Administration of Allogeneic Adipose-Derived Mesenchymal Stem Cells for COVID-19-Induced Acute Respiratory Distress"
                        ],
                        "CentralContactEMail": [],
                        "CentralContactName": [],
                        "CentralContactPhone": [],
                        "CentralContactPhoneExt": [],
                        "CentralContactRole": [],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "September 2021"
                        ],
                        "CompletionDateType": [
                              "Anticipated"
                        ],
                        "Condition": [
                              "Covid19",
                              "ARDS"
                        ],
                        "ConditionAncestorId": [
                              "D000012141",
                              "D000007239",
                              "D000011024",
                              "D000011014",
                              "D000014777",
                              "D000018352",
                              "D000003333",
                              "D000030341",
                              "D000012327",
                              "D000008171",
                              "D000012140"
                        ],
                        "ConditionAncestorTerm": [
                              "Respiratory Tract Infections",
                              "Infections",
                              "Pneumonia, Viral",
                              "Pneumonia",
                              "Virus Diseases",
                              "Coronavirus Infections",
                              "Coronaviridae Infections",
                              "Nidovirales Infections",
                              "RNA Virus Infections",
                              "Lung Diseases",
                              "Respiratory Tract Diseases"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC01",
                              "BC08",
                              "All",
                              "BC23",
                              "Rare"
                        ],
                        "NCTId": [
                              "NCT04728698"
                        ]
                  },
                  {
                        "Rank": 6,
                        "BriefSummary": [
                              "This is a Phase 2 randomized controlled study to assess the safety and efficacy of COVI-MSC in the setting of current standard of care treatments for COVID-19 infection in hospitalized subjects with acute respiratory distress syndrome."
                        ],
                        "BriefTitle": [
                              "Study of Intravenous COVI-MSC for Treatment of COVID-19-Induced Acute Respiratory Distress"
                        ],
                        "CentralContactEMail": [
                              "mroyal@sorrentotherapeutics.com"
                        ],
                        "CentralContactName": [
                              "Mike Royal, MD"
                        ],
                        "CentralContactPhone": [
                              "(858) 203-4100"
                        ],
                        "CentralContactPhoneExt": [
                              "4146"
                        ],
                        "CentralContactRole": [
                              "Contact"
                        ],
                        "CollaboratorClass": [],
                        "CollaboratorName": [],
                        "CompletionDate": [
                              "March 2023"
                        ],
                        "CompletionDateType": [
                              "Anticipated"
                        ],
                        "Condition": [
                              "Covid19"
                        ],
                        "ConditionAncestorId": [
                              "D000012141",
                              "D000007239",
                              "D000011024",
                              "D000011014",
                              "D000014777",
                              "D000018352",
                              "D000003333",
                              "D000030341",
                              "D000012327",
                              "D000008171",
                              "D000012140"
                        ],
                        "ConditionAncestorTerm": [
                              "Respiratory Tract Infections",
                              "Infections",
                              "Pneumonia, Viral",
                              "Pneumonia",
                              "Virus Diseases",
                              "Coronavirus Infections",
                              "Coronaviridae Infections",
                              "Nidovirales Infections",
                              "RNA Virus Infections",
                              "Lung Diseases",
                              "Respiratory Tract Diseases"
                        ],
                        "ConditionBrowseBranchAbbrev": [
                              "BC01",
                              "BC08",
                              "All",
                              "BC23",
                              "Rare"
                        ],
                        "NCTId": [
                              "NCT04903327"
                        ]
                  }
            ]
      }
}